SBEV 424B3: Shelf registration
Endovia Health Sciences
Filed with the SEC on · accession 0001731122-26-001401
SBEV filed a 424B3 (prospectus (offering)) with the SEC on Nov 4, 2026. Endovia Health Sciences filed a 424B3 prospectus covering the resale of up to 1,013,041 shares of common stock by C/M Capital Master Fund, LP under an equity line of credit agreement.
Summary of the filing
Endovia Health Sciences filed a 424B3 prospectus covering the resale of up to 1,013,041 shares of common stock by C/M Capital Master Fund, LP under an equity line of credit agreement. The company may receive up to $29.8 million in gross proceeds from future share sales to the selling stockholder.
Key details
✦ Ask GOAX AI about this filing — what it means for SBEV, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SBEV?
Click hereFrequently asked questions
What did SBEV file with the SEC on Nov 4, 2026?
SBEV filed a 424B3 (Shelf registration). Endovia Health Sciences filed a 424B3 prospectus covering the resale of up to 1,013,041 shares of common stock by C/M Capital Master Fund, LP under an equity line of credit agreement. The company may receive up to $29.8 million in gross proceeds from future share sales to the selling stockholder.
What does a shelf registration mean for SBEV stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B3?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.
Other SBEV SEC filings
- EFFECT · SEC filingNov 3, 2026
- DEF 14A · Stock splitNov 2, 2026
- 8-K · Material agreementOct 27, 2026
- S-1 · Shelf registrationOct 27, 2026
- SCHEDULE 13G · SEC filingOct 22, 2026
- 8-K · Material agreementOct 15, 2026
- 8-K · Secondary offeringOct 6, 2026
- 8-K · Fda approvalOct 5, 2026
- DEF 14A · Board changeOct 5, 2026
- 8-K · Material agreementSep 24, 2026
Get alerts when SBEV files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days